Yuvezzi Solution/ Drops
NDC Package 84892-275-30

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Yuvezzi (carbachol and brimonidine tartrate) solution/ dropses is yUVEZZI™ is indicated for the treatment of presbyopia in adults. This formulation utilizes a solution/ drops delivery system. Marketed by Visus Therapeutics, Inc., this product is identified by NDC 84892-275 and is authorized under FDA application NDA220142.

Identification & Billing

NDC Package Code
84892-275-30
Package Description
6 POUCH in 1 CARTON / 5 VIAL, SINGLE-DOSE in 1 POUCH (84892-275-02) / .16 mL in 1 VIAL, SINGLE-DOSE (84892-275-01)
Product Code
84892-275
11-Digit Billing Format
84892027530
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA
RxNorm Crosswalk
  • RxCUI: 2736933 - brimonidine tartrate 0.1 % / carbachol 2.75 % Ophthalmic Solution
  • RxCUI: 2736933 - brimonidine tartrate 1 MG/ML / carbachol 27.5 MG/ML Ophthalmic Solution
  • RxCUI: 2736939 - YUVEZZI 2.75 % / 0.1 % Ophthalmic Solution
  • RxCUI: 2736939 - brimonidine tartrate 1 MG/ML / carbachol 27.5 MG/ML Ophthalmic Solution [Yuvezzi]
  • RxCUI: 2736939 - Yuvezzi (brimonidine tartrate 0.1 % / carbachol 2.75 % ) Ophthalmic Solution

Clinical Specifications

Proprietary Name
Yuvezzi
Non-Proprietary Name
Carbachol And Brimonidine Tartrate
Substance Name
Brimonidine Tartrate; Carbachol
Dosage Form
Solution/ Drops - A solution which is usually administered in a drop-wise fashion.
Administration Route
Ophthalmic - Administration to the external eye.
Active Ingredient(s)
Pharmacologic Class
Usage Information
YUVEZZI™ is indicated for the treatment of presbyopia in adults.

Regulatory & Marketing

Labeler Name
Visus Therapeutics, Inc.
Product Type
Human Prescription Drug
FDA Application #
NDA220142
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
02-18-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (84892-275). Click a package code to view its specific billing and regulatory data.

84892-275-99
1 POUCH in 1 CARTON / 5 VIAL, SINGLE-DOSE in 1 POUCH (84892-275-02) / .16 mL in 1 VIAL, SINGLE-DOSE (84892-275-01)

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 84892-275-30 identifies a specific commercial package of 6 pouch in 1 carton / 5 vial, single-dose in 1 pouch (84892-275-02) / .16 ml in 1 vial, single-dose (84892-275-01) of Yuvezzi, a human prescription drug labeled by Visus Therapeutics, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This solution/ drops is formulated for ophthalmic use and contains brimonidine tartrate; carbachol as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Visus Therapeutics, Inc. on February 18, 2026. The current certification is valid through December 31, 2027.

How is this Visus Therapeutics, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 84892027530. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
84892-275-30
11-Digit CMS (5-4-2)
84892-0275-30

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.